Eli Lilly’s COVID-19 therapy development partner AbCellera raises $105 million

When AbCellera won a $30 million contract with the Defense Advanced Research Projects Agency to develop therapeutic countermeasures against viral outbreaks two years ago, it’s safe to assume that no one thought the technology would be so vitally important so soon. The work AbCellera was doing was part of a high-priority initiative from DARPA’s Biological […]